Antibiotics - The Perfect Storm

We need new antibiotics to fight infections caused by resistant bacteria. But the marketplace, the structure of the pharmaceutical industry, regulatory agencies, and difficult science are conspiring to deny us the products we need. This blog will present perspectives and developments in the fight for new antibiotics.

Sunday, January 29, 2012

Community Antibiotics - Juice vs. Squeeze?

›
Here it is Sunday, and I have been obsessing on the following conundrum.   (I need therapy)!   I have been railing against the cu...
Friday, January 20, 2012

Antibiotics, Big Pharma and Deals

›
There is a good deal of speculation in the trade press that large pharmaceutical companies are looking for deals – especially ex-US.   T...
1 comment:
Thursday, January 12, 2012

Antibiotic Development - EU vs. US.

›
Image via Wikipedia Image via Wikipedia The European Medicines Agency has now released its new guidance on the development of antibacterial...
Saturday, January 7, 2012

Telavancin, Astellas and Theravance - Implications?

›
According to recent press reports and a regulatory filing by Theravance, the commercialization and manufacturing agreement between Astel...
2 comments:
Tuesday, December 27, 2011

Antibiotics in 2012

›
It is always risky to get into the business of predicting the future.   But, to a certain extent, its what we all do for a living. ...
2 comments:
Friday, December 16, 2011

Its not just big pharma

›
In several previous blogs I have written about dysfunctional aspects of large pharmaceutical companies.  Today I want to explore the foibles...
1 comment:
Friday, December 9, 2011

Antibiotics and Contraceptives

›
The big news this week was that Kathleen Sibelius, Secretary of the Department of Health and Human Services, overruled Commissione...
‹
›
Home
View web version
Powered by Blogger.